To the original poster, don’t listen to this idiot from the leadership team. I want and many others want this discussion to take place.Please stop posting. You’re the only one who cares enough to post long winded rants about Sunovion leadership and how they’re screwing you. Just go to a different company if you’re miserable.
Please stop posting. You’re the only one who cares enough to post long winded rants about Sunovion leadership and how they’re screwing you. Just go to a different company if you’re miserable.
To the original poster, don’t listen to this idiot from the leadership team. I want and many others want this discussion to take place.
If someone does not care about what you wrote, then they don’t have to click on the thread and read it. Let them just sit in their office and pretend Sunovion is a great place to work.
I also hope this thread starts people talking about reality. Because someone is raising an issue that points out the obvious, they must be a disgruntled, terminated employee? Do you think we're all that stupid and blind to what's going on?My friend, they don't work here any longer. What we have is a disgruntled terminated employee with nothing but time on thier weak hands.
time will tell who's really CRAY CRAY, if you can't see the writing on the wall you've got bigger issues.CRAY... CRAY... Table for one!!!
You're annoying (btw, that's how you're supposed to say it.)You’re annoyingly and no one cares. Go away
CRAY... CRAY... Table for one!!!
OP is real and only half the story. Looking around the corner we see:
Dasotraline - Best case, approved with some horrible label, likely case, not approved. Bubye.
APL - A pending nightmare. Commercially unviable (mouth ulcers, etc.), 4 months behind a better product (Acorda) and with a crazy high forecast no one wants to take down because it means admitting to Japan we overpaid for it.
Lonhala- doing ok for now, but will halt in its tracks when Mylan hits the market with the better product, that can be used in a standard jet neb, later this year.
Handhelds- over before it started. What kind of fool buys a 4th entrant product with head to head inferiority data to an in-class competitor.
Latuda - we had a great run, but all good things must come to an end. Generic in short order.
Aptiom/Brovana- little growth and both generic in 2021
40mg Latuda.
Chill bro
CRAY... CRAY... Table for one!!!
OP is real and only half the story. Looking around the corner we see:
Dasotraline - Best case, approved with some horrible label, likely case, not approved. Bubye.
APL - A pending nightmare. Commercially unviable (mouth ulcers, etc.), 4 months behind a better product (Acorda) and with a crazy high forecast no one wants to take down because it means admitting to Japan we overpaid for it.
Lonhala- doing ok for now, but will halt in its tracks when Mylan hits the market with the better product, that can be used in a standard jet neb, later this year.
Handhelds- over before it started. What kind of fool buys a 4th entrant product with head to head inferiority data to an in-class competitor.
Latuda - we had a great run, but all good things must come to an end. Generic in short order.
Aptiom/Brovana- little growth and both generic in 2021
CRAY... CRAY... Table for one!!!
CRAY... CRAY... Table for one!!!
Take your 10 year tenure and beat it....no one cares what you think.It seems all of this is pretty real and that the people saying it is cray cray and that these posts are annoying is in a dream world. The moral is the worst it has ever been and I have worked here for over a decade. If you don’t feel it the moment you walk into the building, you are either an complete idiot or on the leadership team, which still makes you an idiot.
We had a good run with Latuda. Be thankful for all the extra bonus you received. It is now time to face reality.
Eat me. If an dumb ass like you can put in their two cents, someone as intelligent as me can also.Take your 10 year tenure and beat it....no one cares what you think.
no one has said they're getting screwed. no one has said they're miserable. maybe all those words are too much for you to read? someone is calling the facts like they see them. maybe it's all hitting too close to home.
